UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $212,000 | -69.0% | 5,863 | -68.4% | 0.01% | -73.0% |
Q3 2020 | $684,000 | +94.9% | 18,567 | +138.4% | 0.04% | +76.2% |
Q2 2020 | $351,000 | +61.0% | 7,788 | +69.2% | 0.02% | +31.2% |
Q1 2020 | $218,000 | +3014.3% | 4,602 | +2201.0% | 0.02% | – |
Q3 2018 | $7,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |